Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 1,074.15
+10.70 (1.01%)
At close: Sep 25, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 170.13 billion as of September 25, 2026. Its market cap has decreased by -0.20% in one year.
Market Cap
170.13B
Enterprise Value
193.64B
Revenue
86.08B
Ranking
n/a
PE Ratio
48.45
Stock Price
1,074.15
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 170.13B, an increase of 41,729.02%. That is a compound annual growth rate of 25.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 170.13B | -0.06% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 487.30B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 213.11B |
| Caplin Point Laboratories | 212.17B |
| AstraZeneca Pharma India | 167.73B |
| Viyash Scientific | 110.71B |
| Procter & Gamble Health | 90.32B |
| Bliss GVS Pharma | 74.07B |